Live Executive Webinar Free Registration
Securing Europe’s Critical Medicines Through Factory Modernization Under the CMA
- February 18th, 2026
- 04:00 PM GST | 10:00 AM EST | 90 Min.
- Live Presentation + Expert discussion + Q&A
- Medicines for Europe+ SCW.AI
How can Europe realistically deliver on the objectives of the Critical Medicines Act (CMA), rebuild pharmaceutical manufacturing capacity, and reduce medicine shortages?
This webinar opens a discussion on whether factory modernization could represent a scalable and near-term pathway to these goals, and how the CMA framework might support European manufacturers in digital transformation journey.
- 00Days
- 00Hours
- 00Minutes
- 00Seconds
What You Will Get in This Webinar
Competitiveness Gap & Medicine Shortages
The impact of manufacturing limitations, procurement methods, and labor shortages on medicine availability.
Strategic Projects & Factory Modernization
Details on Critical Medicines Act: Especially on factory modernization and its role in mitigating structural medicine shortages.
A Clear Factory Modernization Roadmap
A strategic roadmap—from establishing a data backbone to deploying AI—validated by real-world case studies that demonstrate results.
Direct Q&A with Experts
An opportunity to get your specific questions answered about CMA framework, factory modernization, AI in pharma etc.
About the Speakers
Adrian van den Hoven
Director General
As Director General of Medicines for Europe since 2013, Adrian focuses on market competition, patient access, and sustainable pricing. He advocates for efficient regulatory standards and a coherent EU industrial strategy for the off-patent medicines sector.
Adrian brings deep expertise in European pharmaceutical policy and industrial strategy. He will address the structural challenges facing off-patent medicine manufacturers and the role of CMA in ensuring sustainable access to medicines.
Evren Ozkaya
Founder and CEO
Evren Ozkaya, Ph.D is the Founder & CEO of SCW.AI, a global leader in Digital Factory solutions for pharmaceutical industry. As a former supply chain executive at Sandoz/Novartis and a former management consultant at McKinsey’s Supply Chain Practice, Evren led various business transformation programs in industries such as pharmaceuticals, healthcare, consumer goods, industrial, logistics and private equity, advising over 100+ companies & organizations.
With over 20 years of experience in pharmaceutical manufacturing and digital transformation, Evren will present a practical, factory-level perspective on how modernization translates into capacity and assess AI readiness of the European pharma industry.
Who Should Join This Webinar
This webinar is designed for stakeholders shaping the future of pharmaceutical manufacturing and medicine supply in Europe, including:
- Experts from pharmaceutical manufacturing, operations, and supply chain functions
- EU and national policymakers involved in the Critical Medicines Act, procurement, and industrial policy
- Digital transformation, Industry 4.0, and IT teams
- Quality, regulatory, and compliance professionals navigating GMP modernization and sustainability
- Industry associations, and healthcare stakeholders focused on supply security
- Consultants focused on European pharmaceutical industry.
Complimentary Free eBook: CMA & Factory Modernization Guide
In addition to the webinar, we released a free eBook: ‘Securing Europe’s Medicine Supply: Can Factory Modernization Deliver Resilience Under the Critical Medicines Act?‘ featuring contributions from Medicines for Europe. We encourage all attendees to download the guide beforehand to maximize the session’s value. If you cannot join us live, this eBook is an essential resource for understanding the European pharmaceutical market, the CMA, factory modernization and AI readiness of manufacturers.
Reserve Your Spot for Webinar Now!
This webinar is free to attend, but registration is required.
Fill out the exclusive registration form below.
Our team will contact you shortly and provide your final access link.